Valo Health Acquires Tara Biosystems Creating First Of Its Kind Vertically Integrated Cardiovascular Platform
Acquiring Company
Valo
Acquired Company
TARA Biosystems, Inc.
Description
Valo Health, LLC ("Valo"), announced today the acquisition of TARA Biosystems, Inc. ("TARA"), a New York City-based cardiovascular disease biotechnology company, creating the first of its kind vertically integrated cardiovascular drug discovery and development platform. The combination of TARA's proprietary human three-dimensional tissue engineering and cardiac disease modeling capabilities with Valo's Opal Computational PlatformTM positions Valo to transform cardiovascular disease drug discovery and development.
Quick answer
Valo is acquiring TARA Biosystems, Inc., announced April 5, 2022. Valo is based in United States.
- Who acquired TARA Biosystems, Inc?
- Valo agreed to acquire TARA Biosystems, Inc. on April 5, 2022.
- How much did Valo pay for TARA Biosystems, Inc?
- The deal value was not disclosed.
- What does Valo do?
- Valo is a technology company built to transform drug discovery and development using large-scale data and AI-powered computation.
- Where are Valo and TARA Biosystems, Inc. based?
- Valo is based in United States. TARA Biosystems, Inc. is based in New York, New York, United States.
- Who are the decision-makers at Valo?
- Fundz holds 1 contact at Valo. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Biotechnology and Health Care
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Aprea Therapeutics Announces Acquisition Of Atrin Pharmaceuticals Inc. And Reports First Quarter 2022 Financial Results (May 16, 2022)
- Pfizer To Acquire Biohaven Pharmaceuticals (May 10, 2022)
- Hikma Completes Acquisition Of Custopharm (April 21, 2022)
- Consegna Pharma Acquires Fathom Pharma To Strengthen Initiatives That Address The Opioid Crisis (April 19, 2022)
- Regeneron To Acquire Checkmate Pharmaceuticals And Its Investigational Immune Activator For Potential Use In Multiple Tumor Types (April 19, 2022)
- Halozyme To Acquire Antares Pharma To Create A Specialty Product And Drug Delivery Leader (April 13, 2022)
Who to call at Valo, and when
When Valo changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Valo raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Valo, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Valo. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Valo makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired TARA Biosystems, Inc.?
TARA Biosystems, Inc. was acquired by Valo, based in United States. The deal was reported on April 5, 2022. Valo is a technology company built to transform drug discovery and development using large-scale data and AI-powered computation. Valo is privately held and operates in Biotechnology.
When did Valo acquire TARA Biosystems, Inc.?
Valo's acquisition of TARA Biosystems, Inc. was reported on April 5, 2022. Valo Health, LLC ("Valo"), announced today the acquisition of TARA Biosystems, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does TARA Biosystems, Inc. do?
Headquartered in New York City, TARA Biosystems harnesses innovations in stem cell biology and tissue engineering to generate in vitro biology that recapitulates human physiology with unprecedented fidelity. It is privately held, operating in Health Care, and is based in New York.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.